Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy [Phase 2]
Phase 2 clinical trial evaluating a preoperative high-arginine nutritional supplement before radical cystectomy for bladder cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Chemoradiotherapy for Recurrent T1G3 Bladder Cancer [Phase 4]
Phase 4 clinical trial update evaluating chemoradiotherapy for recurrent T1G3 bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
A completed clinical trial update reports that the NMP22 biomarker test shows improved sensitivity for detecting bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. [Phase 4]
A Phase 4 trial assessing whether TachoSil reduces lymphoceles after extended pelvic lymph node dissection in prostate or bladder cancer; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy [Phase 2]
A Phase 2 trial evaluating gemcitabine plus pazopanib for chemotherapy-naïve, advanced/metastatic urothelial carcinoma ineligible for cispla…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) [Phase 3]
Phase 3 clinical trial update for single-dose intravesical apaziquone after TURBT in noninvasive bladder cancer patients; study completed wi…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization [NA]
An exploratory study evaluating advanced PET/MRI metrics for bladder cancer characterization; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: An Educational Intervention for Patients With Bladder Cancer [NA]
The clinical trial evaluating an educational intervention for patients with bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
This clinical trial update reports on a study predicting impaired survival in elderly bladder cancer patients who opt for radical cystectomy…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Detection of K14 in Bladder Cancer With a Non Invasive Technique
A clinical trial evaluating a non-invasive technique to detect K14 in bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods
The update describes calibration of urine pH strips for National Cancer Institute bladder cancer case-control studies and a comparison of DN…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Pillars4Life Trial [NA]
Duke University's Pillars4Life trial has completed, studying multiple cancer indications including breast, lung, esophageal, colon, pancreat…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy [Phase 2]
A Phase 2 trial evaluating adjuvant sunitinib (Sutent) after cystectomy for high-risk urothelial carcinoma of the bladder was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract [Phase 1]
This clinical trial update reports termination of a Phase 1B study of B-701 in combination with pembrolizumab for metastatic bladder/urothel…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy [Phase 3]
Phase 3 trial evaluating pemetrexed maintenance therapy in patients with urothelial carcinoma who completed first-line platinum-based chemot…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients [Phase 2]
Phase 2 safety study evaluating escalating doses of TC-3 Gel in combination with intravesical mitomycin C for non-muscle invasive bladder ca…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer [Phase 2]
Phase II trial of pazopanib in combination with weekly paclitaxel in refractory urothelial cancer has completed, with results posted on 2017…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer [Phase 3]
Phase 3 trial of a combination chemotherapy regimen for bladder cancer was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer [Phase 2]
Phase 2 trial evaluating intravesical rAd-IFN/Syn3 for BCG-refractory or relapsed bladder cancer has completed and posted results. The spons…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Bupropion in Helping Adults Stop Smoking [Phase 2]
A Phase 2 clinical trial update for bupropion examining smoking-cessation outcomes in adults; the study is completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Zinc Supplements in Lowering Cadmium Levels in Smokers [Phase 2]
Phase 2 clinical trial evaluated zinc supplementation to lower cadmium levels in smokers; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer [Phase 2]
Phase 2 trial evaluating nivolumab in participants with metastatic or unresectable bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
This document reports five-year follow-up results on the efficacy and safety of electronic cigarettes. The trial status is listed as UNKNOWN…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) [Phase 2]
Phase 2 trial update for atezolizumab in locally advanced or metastatic urothelial/bladder cancer completed with posted results.